Ianalumab (Anti-TNFRSF13C / BAFFR / CD268)
Ianalumab (Anti-TNFRSF13C / BAFFR / CD268) is a fully human combinatorial antibody library (HuCAL)-derived monoclonal antibody targeting the B-cell-activating factor receptor (BAFF-R), with potential anti-inflammatory and antineoplastic activities. MW : 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2329 |
Sku # | A2329-1mg |
Pricing | 1mg, $270.00 |